SUBSCRIBE
SUBSCRIBE
News   Policy

Sanofi-Aventis (France) Settles with Sandoz Pharmaceuticals, Teva Pharmaceutical Industries Limited on Eloxatin Patent

April 1, 2010 | 
1 min read
Reuters -- French drugmaker Sanofi-Aventis (SASY.PA) has settled a patent law suit over cancer drug Eloxatin, putting a block on several other drugmakers selling their generic versions from late June until August 2012.
Legal
Sanofi (France)
MORE ON THIS TOPIC
Protection From Tariffs as an An umbrella that shields against import and export tariff taxes as a trade war storm increasing prices and straining supply chains as a business metaphor and a symbol for resilience in times of crisis and economic downturn.
Tariffs
Trump Sets 100% Pharma Tariff Deadline for October 1
September 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Stack of coins balancing on seesaw over a bottle of pills.
Drug pricing
Trump Admin Readies Proposed Rule To Lower US Drug Prices
September 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Image of padlock on U.S. flag
Job Trends
$100,000 H-1B Fee Leaves Biopharma Grappling With Impact
September 25, 2025
 · 
6 min read
 · 
Angela Gabriel
Black swan theory or a black swan event is a term used to describe a very rare or otherwise unexpected event that has a major effect, such as a financial crash or pandemic. The term is based on an ancient saying which presumed black swans did not exist.
Rare diseases
Rare Disease Experts See Futility in FDA’s Proposed Framework
September 22, 2025
 · 
5 min read
 · 
Dan Samorodnitsky